Prostate-specific membrane antigen (PSMA) is a transmembrane protein, the expression of which is significantly increased in prostate cancer, and ​as such ​it can be targeted with radiotracers for use in positron-emission tomography (PET) scans [3]. This evidence concerns the gene FOLH1 and prostate carcinoma.